OS. MOZARTA 1/29 31-232 KRAKÓW
(+48) 607 345 792
centrumhta@centrumhta.com
SKONTAKTUJ SIĘ

Conference abstracts

Conference abstracts

Conference abstracts

  • Kawalec P, Malinowski K. Relation of Polish HTA recommendations and decisions issued by selected national HTA agencies. PHP164. ISPOR 22nd Annual International Meeting, Maj 2017, Boston, USA.
  • Kawalec P, Malinowski K, Stawowczyk E. Relation between Polish HTA recommendations and reimbursement decisions. PHP163. ISPOR 22nd Annual International Meeting, Maj 2017, Boston, USA.
  • Kawalec P, Stawowczyk E. A physician based assessment of disease activity, quality of life and costs of ulcerative colitis in Poland. PSY58. ISPOR 22nd Annual International Meeting, Maj 2017, Boston, USA.
  • Holko P, Kawalec P, Stawowczyk E. Direct costs of inflammatory bowel diseases therapy in Poland – nationwide database analysis. ISPOR 20th Annual European Congress. listopad, 2017 Glasgow, Wielka Brytania.
  • Kawalec P. Tyrosine kinase inhibitors (TKI) for the treatment of advanced medullary thyroid carcinoma: a systematic review and indirect comparison. Value in Health 2016, 19: A708. ISPOR 19th Annual European Congress, pażdziernik 2016, Wiedeń, Austria.
  • Kawalec P, Stawowczyk E. Disease activity, quality of life and indirect costs associated with ulcerative colitis in Poland. Value in Health, 2016; 19: A585. ISPOR 19th Annual European Congress, pażdziernik 2016, Wiedeń, Austria.
  • Kawalec P, Malinowski K. Indirect costs genereted by absenteeism associated with insulin dependent diabetes mellitus (IDDM) in Poland. Value in Health, 2016: 19: A670. ISPOR 19th Annual European Congress, pażdziernik 2016, Wiedeń, Austria.
  • Malinowski K, Kawalec P. Indirect costs generated by absenteeism associated with sclerosis multiplex in Poland. PSY54. ISPOR 19th Annual European Congress, pażdziernik 2016, Wiedeń, Austria.
  • Kawalec P, Stawowczyk E. Indirect costs associated with ulcerative colitis in Poland. Value in Health, 2016; 19: A584. ISPOR 19th Annual European Congress, pażdziernik 2016, Wiedeń, Austria.
  • Kawalec P, Malinowski K. Status of orphan drugs and reimbursement recommendations and decisions in analysed European countries. Value in Health, 2016; 19: a598-9. ISPOR 19th Annual European Congress, pażdziernik 2016, Wiedeń, Austria.
  • Kawalec P, Malinowski K, Moćko P. The indirect costs of types 1 diabetes mellitus associated with absenteeism in Poland in 2013. Value in Health. 2015; 18(7): A603. ISPOR 18th Annual European Congress, listopad 2015, Mediolan, Włochy.
  • Moćko P, Kawalec P. The indirect costs of multiple sclerosis associated with absenteeism in Poland in 2013. Value in Health. 2015; 18(7): A754. ISPOR 18th Annual European Congress, listopad 2015, Mediolan, Włochy.
  • Kawalec P, Moćko P, Malinowski K. The indirect costs of inflammatory bowel disease associated with absenteeism in Poland in 2013. Value in Health. 2015; 18(7): A665. ISPOR 18th Annual European Congress, listopad 2015, Mediolan, Włochy.
  • Malinowski K, Kawalec P. The association between disease activity and quality of life among patients with ankylosing spondylitis in polish population. Value in Health. 2015; 18(7): A653. ISPOR 18th Annual European Congress, listopad 2015, Mediolan, Włochy.
  • Kawalec P, Malinowski K. The association between disease activity and indirect costs of absenteeism and presenteeism generated by patients with ankylosing spondylitis in Polish population. Value in Health. 2015; 18(7): A642-3. ISPOR 18th Annual European Congress, listopad 2015, Mediolan, Włochy.
  • Kawalec P. Recommendations and reimbursement status of orphan drugs in UE countries. Value in Health. 2015; 18(7): A678-9. ISPOR 18th Annual European Congress, listopad 2015, Mediolan, Włochy.
  • Kawalec P, Malinowski K. Cost of absenteeism in psoriatic and enteropathic arthtopathies based on Real-Life data from Poland’s Social Insurance Institution database in 2013. Value in Health. 2015; 18(7): A665. ISPOR 18th Annual European Congress, listopad 2015, Mediolan, Włochy.
    Malinowski K, Kawalec P. Costs of absenteeism in ankylosing spondylitis based on real-life data from Poland’s Social Insurance Institution database in 2013. Value in Health. 2015; 18(7): A642. ISPOR 18th Annual European Congress, listopad 2015, Mediolan, Włochy.
  • Moćko P, Kawalec P. The indirect costs of multiple sclerosis associated with absenteeism in Poland. Value in Health. 2014; 17(7): A528-9. ISPOR 17th Annual European Congress, listopad 2014, Amsterdam, Holandia.
  • Kawalec P. Indirect costs of diabetes mellitus from the perspective of the social insurance institution (ZUS) in Poland. Value in Health. 2014; 17(7): A340. ISPOR 17th Annual European Congress, listopad 2014, Amsterdam, Holandia.
  • Kawalec P. Direct costs of diabetes mellitus in Poland. Value in Health. 2014; 17(7): A339. ISPOR 17th Annual European Congress, listopad 2014, Amsterdam, Holandia.
  • Stawowczyk E, Holko P, Kawalec P, Borowiec L, Filipiak KJ. Cost-utility analysis of hypertensive treatment with indapamide and amlodipine single-pill combination in the Polish setting. Value in Health. 2014; 17(7): A491. ISPOR 17th Annual European Congress, listopad 2014, Amsterdam, Holandia.
  • Kawalec P, Malinowski K. Costs of absenteeism in psoriatic and enteropathic arthropathies based on real-life data from Poland’s social insurance institution database in 2012. Value in Health. 2014; 17(7): A528. ISPOR 17th Annual European Congress, listopad 2014, Amsterdam, Holandia.
  • Malinowski K, Kawalec P. Costs of absenteeism in ankylosing spondylitis based on real-life data from Poland’s social insurance institution database in 2012. Value in Health. 2014; 17(7): A529. ISPOR 17th Annual European Congress, listopad 2014, Amsterdam, Holandia.
  • Kawalec P, Stawowczyk E, Holko P, Borowiec L, Filipiak KJ. Budget impact analysis of hypertensive treatment with indapamide and amlodipine single-pill combination in the Polish setting. Value in Health. 2014; 17(7): A479. ISPOR 17th Annual European Congress, listopad 2014, Amsterdam, Holandia.